Margarita is Managing Director at Abbvie Ventures. She brings 20 years of dealmaking experience, with over 10 years in biotech and pharma M&A, licensing, and public and private financings. Margarita has lead and managed investments in over two dozen biotech companies in the US and Europe. She is currently responsible for AbbVie’s investments in Morphic Therapeutics, Palleon Pharmaceuticals, eFFECTOR Therapeutics, CARMA Therapeutics and Jnana Therapeutics.
Most recently, Margarita was a Director with Abbott’s Global Pharmaceutical Licensing & Acquisitions group. Before joining Abbott, Margarita practiced as a corporate and securities lawyer in Silicon Valley with the firm of Brobeck Phleger & Harrison, advising in equity financings, M&A and IPOs.
Margarita currently serves on the Board of the MidAmerica Healthcare Investors Network, and the Advisory Board of the New England Venture Capital Association.